Literature DB >> 1537518

Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum.

A Pietrangelo1, E Rocchi, G Casalgrandi, G Rigo, A Ferrari, M Perini, E Ventura, G Cairo.   

Abstract

To gain insights at the molecular level into the expression of iron-regulated genes [transferrin (Tf), transferrin receptor (TfR), and ferritin H and L subunits] in human intestinal areas relevant to iron absorption, the steady-state levels of specific messenger RNAs (mRNAs) were analyzed in gastric and duodenal samples obtained from 6 normal subjects, or 10 patients with anemia, 14 patients with untreated iron overload, and 8 patients with various gastrointestinal disorders. No Tf mRNA was detected in human gastroduodenal tissue, confirming earlier findings in the rat. In normal subjects, although higher levels of ferritin H- and L-subunit mRNAs were consistently found in duodenal than in gastric samples, no differences in the content of TfR transcripts were detected. However, a dramatic increase in TfR mRNA levels was specifically found in duodenal samples from subjects with mild iron deficiency but severe anemia. This response of the TfR gene is presumably secondary to decreased cellular iron content due to its accelerated transfer into the bloodstream, as also indicated by the low levels of ferritin subunit mRNAs found in the same tissue samples, and is not linked to faster growth rate of mucosal cells because no changes in duodenal expression of histone, a growth-related gene, were detected. In patients with secondary iron overload, a down-regulation of duodenal TfR gene expression and a concomitant increase in ferritin mRNA content were documented. On the contrary, a lack of TfR gene down-regulation and an abnormally low accumulation of ferritin H- and L-subunit mRNAs were detected in the duodenums of subjects with idiopathic hemochromatosis. Whether these molecular abnormalities in idiopathic hemochromatosis are relevant to the metabolic defect(s) of the disease is presently unknown.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537518     DOI: 10.1016/0016-5085(92)90161-q

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

1.  The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulin.

Authors:  Jian Wang; Guohua Chen; Kostas Pantopoulos
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 2.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 3.  Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways.

Authors:  P W Swaan
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

4.  Regulation of intestinal non-haem iron absorption.

Authors:  M Lombard; E Chua; P O'Toole
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 5.  The role of iron and iron binding proteins in lymphocyte physiology and pathology.

Authors:  J D Kemp
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

6.  The hemochromatosis protein HFE inhibits iron export from macrophages.

Authors:  Hal Drakesmith; Emma Sweetland; Lisa Schimanski; Jon Edwards; Diana Cowley; Mubeen Ashraf; Judy Bastin; Alain R M Townsend
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

7.  Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis.

Authors:  Abdul Waheed; Jeffrey H Grubb; Xiao Yan Zhou; Shunji Tomatsu; Robert E Fleming; Mark E Costaldi; Robert S Britton; Bruce R Bacon; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

8.  Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents.

Authors:  A Pietrangelo; R Gualdi; G Casalgrandi; G Montosi; E Ventura
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.

Authors:  T Kelleher; E Ryan; S Barrett; M Sweeney; V Byrnes; C O'Keane; J Crowe
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

10.  Function of the hemochromatosis protein HFE: Lessons from animal models.

Authors:  Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.